Analyst Price Target is $179.00
▲ +33.83% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for Ascendis Pharma A/S in the last 3 months. The average price target is $179.00, with a high forecast of $262.00 and a low forecast of $113.00. The average price target represents a 33.83% upside from the last price of $133.75.
Current Consensus is
Moderate Buy
The current consensus among 10 polled investment analysts is to moderate buy stock in Ascendis Pharma A/S. This Moderate Buy consensus rating has held steady for over two years.